Affordable GLP-1 weight loss medication starting at $199/mo. Licensed providers, free shipping.
Free consultation · No commitment · Results in weeks
From 2,000+ patients · Mounjaro Cost is already seeing results
Mounjaro Cost: Weight Method offers compounded GLP-1 treatment starting at $199/month. Compounded semaglutide from $199/month and tirzepatide from $329/month, prescribed by licensed providers. Includes virtual medical consultation and free direct shipping.
Key Fact
Weight Method's compounded tirzepatide program is $329/month, all-inclusive, with no insurance required. Weight Method does not dispense brand-name Mounjaro®. Mounjaro is FDA-approved for type 2 diabetes; compounded tirzepatide is not FDA-approved.
Source: Weight Method pricing, February 2026
Mounjaro's pricing follows Eli Lilly's specialty pharmaceutical model. Actual pharmacy prices vary by location and dose. Cash-pay discount tools like GoodRx may bring prices down somewhat, but availability is inconsistent. Insurance coverage for Mounjaro is strongest when prescribed for type 2 diabetes, where it may sit on a preferred brand tier with a lower copay. For weight loss, coverage is rare since Mounjaro's FDA label is diabetes-specific. The weight-management-labeled tirzepatide product is Zepbound®. Weight Method's $329/month compounded tirzepatide pricing is a flat all-inclusive monthly fee — the same from the starting 2.5mg through the maximum 15mg. Compounded tirzepatide is not FDA-approved.
Weight Method's compounded tirzepatide program is a flat $329/month all-inclusive fee that does not change with insurance decisions or formulary updates. Brand-name Mounjaro purchased cash-pay at a retail pharmacy is set by Eli Lilly and is a much larger monthly outlay for patients without coverage. The decision between them is not purely financial — Mounjaro is FDA-approved (for type 2 diabetes), while compounded tirzepatide is not. Published clinical-trial outcomes describe the FDA-approved brand-name tirzepatide products and should not be assumed to apply to compounded tirzepatide, which is not FDA-evaluated. Weight Method's compounded tirzepatide program bundles medication, provider consultations, dosing management, and shipping into one predictable monthly cost, eliminating the incidental expenses (specialist visits, lab work, pharmacy dispensing fees) of the conventional pathway.
Answer a few quick questions to see if you qualify for GLP-1 medication.
Check EligibilityCompounded GLP-1 medications dispensed by U.S.-licensed 503A pharmacies.

Compounded semaglutide. Once-weekly subcutaneous injection.

Compounded tirzepatide. Dual-action GLP-1/GIP, once-weekly subcutaneous injection.
We offer the most affordable GLP-1 treatments. Starting at $199/month.
See PricingFree consultation. No commitment.